Biogen Inc. buy Royal Bank of Canada
Start price
02.05.25
/
50%
€109.15
Target price
02.05.26
€181.51
Performance (%)
7.38%
Price
27.08.25
€117.20
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 7.38%. This prediction currently runs until 02.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -1.760% | -1.760% |
| iShares Core DAX® | -0.959% | -0.959% |
| iShares Nasdaq 100 | 1.557% | 2.255% |
| iShares Nikkei 225® | -0.963% | 3.393% |
| iShares S&P 500 | 1.513% | 2.437% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $217.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat